WHO Global TB Report 2025

Echoes of Resilience: Unpacking the 2025 Global TB Report
In the shadow of a silent killer, sparks of hope ignite a bolder fight: join us in turning
data into destiny for Nigeria’s TB warriors. As the World Health Organization unveils its
Global TB Report 2025, just few days ago on November 12, it’s a mirror reflecting 2024’s
triumphs and trials in the battle against tuberculosis. Remember, these insights capture last
year’s story; the full chapter on 2025 won’t unfold until November 2026. Yet, what stares
back is a tapestry of bittersweet truths: glimmers of progress that fuel our dreams,
shadowed by funding shortfalls that stir a righteous fire within us.
At Amity Health Foundation Nigeria, we see not just numbers, but lives! yours, mine, our
neighbors’ hanging in the balance. What if ignoring TB’s whisper today becomes tomorrow’s
roar? Let’s dive deeper, and let this report provoke us to act. Shadows That Linger: The
Alarms We Can’t Afford to Snooze! Imagine a thief in the night, airborne and unrelenting,
claiming more lives than any other infectious foe.
In 2024, Mycobacterium tuberculosis stole 1.23 million souls worldwide yet again, the
deadliest single agent of infectious death. We’re all vulnerable; no borders, no privileges
shield us from its grasp. Why, then, do we slumber? The resistance riddle deepens our
unease: For years, drug-resistant TB has mocked our efforts, with only two in five cases
164,545 out of 390,000 reaching diagnosis and treatment. It’s a gap that echoes neglect,
begging the question: How many more must suffer before we bridge it? New weapons in our
arsenal—rapid molecular tests promise swift victories, but their reach is a trickle, not a
torrent. Just 54% of diagnosed TB patients benefited from these modern marvels. Access
delayed is lives denied; what hidden barriers keep these tools from our communities?
And prevention? It’s the forgotten shield. Only one in four household contacts received
preventive therapy! a regimen boasting 60% efficacy, rivalling the vaccines we eagerly
await. In a nation like Nigeria, where TB whispers through homes and streets, isn’t this the
moment to ask: Are we guardians or bystanders? Dawn’s Promise: Threads of Hope
Weaving a Brighter Horizon yet, amid the storm, beacons flicker. TB incidence dipped by
1.7% from 2023, a quiet victory whispering that decline is possible if we amplify our resolve.
In high-burden lands like ours, visionary leaders and tireless advocates are rewriting the
script. Screening and early diagnosis drives have surged, diagnosing, and treating a record
8.3 million people up from 8.2 million last year. This isn’t luck; it’s the raw ambition of
communities rising, a testament to what happens when we hunt TB before it hunts us.
Could Nigeria lead this charge? Diagnosis is just the spark; treatment fans the flame. With
88% success for drug-sensitive TB and 71% for resistant strains including breakthroughs
from scaled-up new regimens we’re proving that once we find them, we can heal them. It’s a
reminder: Every success story is a seed for the next. The horizon brims with innovation:
Near-point-of-care diagnostics on the cusp of reality, 18 vaccine candidates charging
forward, and 42 clinical trials birthing smarter treatments. These aren’t distant dreams
they’re invitations.
What role will you play in accelerating them to our doorsteps? The Fire of Frustration: Fuel
for Unyielding Commitment. Our deepest ache? The choices we’ve made or failed to make.
TB isn’t just a health crisis; it’s a global security siren, airborne and borderless, with the
power to upend economies and families. Yet, we sideline it, year after year, with a paltry
US$5.9 billion for implementation in 2024 miles from the UN High-Level Meeting’s US$22
billion pledge. Research starves too, scraping by on US$1.2 billion against a US$5 billion
call.